{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:15:41Z","timestamp":1775099741525,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Telethon Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["825825"],"award-info":[{"award-number":["825825"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ymthe.2025.12.036","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T16:05:44Z","timestamp":1766592344000},"page":"1976-1996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tweaking lentiviral vector design balances efficacy and safety in liver-directed gene therapy for familial hypercholesterolemia"],"prefix":"10.1016","volume":"34","author":[{"given":"Cesare","family":"Canepari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Milani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Degl\u2019Innocenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Monti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Volpin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Starinieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Fabiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialucia","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Ormoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Gazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Norata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Brombin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Cugnata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Cristofori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Montini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Sanvito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-997X","authenticated-orcid":false,"given":"Alessio","family":"Cantore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.12.036_bib1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(21)02001-8","article-title":"Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study","volume":"399","author":"Tromp","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.12.036_bib2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1073\/pnas.71.3.788","article-title":"Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity","volume":"71","author":"Brown","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.036_bib3","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2025.12.036_bib4","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1073\/pnas.84.19.6919","article-title":"Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding","volume":"84","author":"Innerarity","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.036_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.12.036_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ymthe.2025.12.036_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fmmed.2023.1140997","article-title":"Gene transfer and genome editing for familial hypercholesterolemia","volume":"3","author":"Canepari","year":"2023","journal-title":"Front. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.12.036_bib8","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/bloodadvances.2023010511","article-title":"Hemophilia B and gene therapy: a new chapter with etranacogene dezaparvovec","volume":"8","author":"Anguela","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.12.036_bib9","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1182\/bloodadvances.2023011847","article-title":"Roctavian Gene Therapy for Hemophilia A","volume":"8","author":"Samelson-Jones","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.12.036_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCRESAHA.115.304008","article-title":"AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia","volume":"115","author":"Somanathan","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2025.12.036_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/humc.2017.007","article-title":"Nonclinical Pharmacology\/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia","volume":"28","author":"Greig","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.12.036_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/humc.2017.014","article-title":"Non-Clinical Study Examining AAV8.TBG.hLDLR Vector-Associated Toxicity in Chow-Fed Wild-Type and LDLR(+\/-) Rhesus Macaques","volume":"28","author":"Greig","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.12.036_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2021.04.017","article-title":"Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia","volume":"22","author":"Wang","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.12.036_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7325","article-title":"Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates","volume":"11","author":"Milani","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.12.036_bib15","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1038\/s41467-022-30102-3","article-title":"Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates","volume":"13","author":"Milani","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.036_bib16","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1038\/s41467-022-32576-7","article-title":"In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions","volume":"13","author":"Nicolas","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.036_bib17","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1038\/s41467-025-60073-0","article-title":"Enhancing the potency of in vivo lentiviral vector mediated gene therapy to hepatocytes","volume":"16","author":"Canepari","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.036_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa1405","article-title":"Liver-directed lentiviral gene therapy in a dog model of hemophilia B","volume":"7","author":"Cantore","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.12.036_bib19","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.1214441110","article-title":"LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus","volume":"110","author":"Finkelshtein","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.036_bib20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s41467-018-03432-4","article-title":"Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein","volume":"9","author":"Nikolic","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.036_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1755-7682-3-36","article-title":"LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives","volume":"3","author":"Al-Allaf","year":"2010","journal-title":"Int. Arch. Med."},{"key":"10.1016\/j.ymthe.2025.12.036_bib22","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.1128\/JVI.01869-15","article-title":"Release of Vesicular Stomatitis Virus Spike Protein G-Pseudotyped Lentivirus from the Host Cell Is Impaired upon Low-Density Lipoprotein Receptor Overexpression","volume":"89","author":"Otahal","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.12.036_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ymthe.2004.01.015","article-title":"Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy","volume":"9","author":"Kankkonen","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.036_bib24","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1038\/s41598-019-43459-1","article-title":"Bile-duct proliferation as an unexpected side-effect after AAV2-LDLR gene transfer to rabbit liver","volume":"9","author":"Hytonen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.12.036_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/gt.2009.3","article-title":"Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS","volume":"16","author":"Zanta-Boussif","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.036_bib26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.gt.3302698","article-title":"Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression","volume":"13","author":"Schambach","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.036_bib27","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1182\/blood-2007-03-078493","article-title":"A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice","volume":"110","author":"Brown","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.12.036_bib28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.gt.3302170","article-title":"Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro","volume":"11","author":"Schauber","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.036_bib29","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/s44321-024-00072-8","article-title":"GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice","volume":"16","author":"Milani","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.12.036_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/hum.2012.108","article-title":"Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia","volume":"24","author":"Kassim","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.036_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejphar.2017.05.010","article-title":"Animal models of atherosclerosis","volume":"816","author":"Emini Veseli","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.12.036_bib32","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.atherosclerosis.2007.07.022","article-title":"Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa","volume":"196","author":"Homer","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymthe.2025.12.036_bib33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccr.2014.03.005","article-title":"Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation","volume":"25","author":"Pilati","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2025.12.036_bib34","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/gutjnl-2019-319790","article-title":"Recurrent chromosomal rearrangements of ROS1, FRK and IL6 activating JAK\/STAT pathway in inflammatory hepatocellular adenomas","volume":"69","author":"Bayard","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.ymthe.2025.12.036_bib35","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/mt.2014.3","article-title":"Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo","volume":"22","author":"Cesana","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.036_bib36","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1172\/JCI62189","article-title":"Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations","volume":"122","author":"Cesana","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.12.036_bib37","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1073\/pnas.93.13.6393","article-title":"Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100","volume":"93","author":"Farese","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.036_bib38","article-title":"In vivo liver targeted genome editing as therapeutic approach: progresses and challenges","volume":"6","author":"Simoni","year":"2024","journal-title":"Front Genome"},{"key":"10.1016\/j.ymthe.2025.12.036_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/JOE-15-0023","article-title":"Adrenocortical LDL receptor function negatively influences glucocorticoid output","volume":"226","author":"van der Sluis","year":"2015","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ymthe.2025.12.036_bib40","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(84)91876-2","article-title":"Heart-liver transplantation in a patient with familial hypercholesterolaemia","volume":"1","author":"Starzl","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.12.036_bib41","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2217T to G\u2217C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.036_bib42","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.036_bib43","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/cvr\/cvae136","article-title":"Advances in nucleic acid-targeted therapies for cardiovascular disease prevention","volume":"120","author":"Makhmudova","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ymthe.2025.12.036_bib44","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.036_bib45","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-024-07087-8","article-title":"Durable and efficient gene silencing in vivo by hit-and-run epigenome editing","volume":"627","author":"Cappelluti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.036_bib46","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/d41586-023-03543-z","article-title":"First trial of 'base editing' in humans lowers cholesterol - but raises safety concerns","volume":"623","author":"Naddaf","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.036_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/v13081526","article-title":"Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases","volume":"13","author":"Poletti","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.12.036_bib48","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.12.036_bib49","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/j.gastro.2016.11.042","article-title":"Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation","volume":"152","author":"Nault","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2025.12.036_bib50","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa2405541","article-title":"Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy","volume":"391","author":"Duncan","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.12.036_bib51","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41586-024-08250-x","article-title":"Long-term lineage commitment in hematopoietic stem cell gene therapy","volume":"636","author":"Calabria","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.036_bib52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/jgm.473","article-title":"Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage","volume":"6","author":"Cichon","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2025.12.036_bib53","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003029","article-title":"Lifelong Reduction in LDL (Low-Density Lipoprotein) Cholesterol due to a Gain-of-Function Mutation in LDLR","volume":"14","author":"Bjornsson","year":"2021","journal-title":"Circ. Genom. Precis. Med."},{"key":"10.1016\/j.ymthe.2025.12.036_bib54","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hep4.1858","article-title":"Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol","volume":"6","author":"Ioannou","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ymthe.2025.12.036_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.0959-9673.2004.00375.x","article-title":"Reduced progression of atherosclerosis in apolipoprotein E-deficient mice treated with lacidipine is associated with a decreased susceptibility of low-density lipoprotein to oxidation","volume":"85","author":"Cristofori","year":"2004","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ymthe.2025.12.036_bib56","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jhep.2025.06.018","article-title":"Spatiotemporal liver dynamics shape hepatocellular heterogeneity and impact in vivo gene engineering","volume":"83","author":"Milani","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymthe.2025.12.036_bib57","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41591-021-01389-4","article-title":"Retrieval of vector integration sites from cell-free DNA","volume":"27","author":"Cesana","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.12.036_bib58","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12859-017-1937-9","article-title":"VISPA2: a scalable pipeline for high-throughput identification and annotation of vector integration sites","volume":"18","author":"Spinozzi","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ymthe.2025.12.036_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac551","article-title":"ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications","volume":"24","author":"Pais","year":"2023","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ymthe.2025.12.036_bib60","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/bioinformatics\/bts004","article-title":"Estimating abundances of retroviral insertion sites from DNA fragment length data","volume":"28","author":"Berry","year":"2012","journal-title":"Bioinformatics"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:36:26Z","timestamp":1775057786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625010597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1525001625010597"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.036","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tweaking lentiviral vector design balances efficacy and safety in liver-directed gene therapy for familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}